Skip to content 
Medications improve and save millions of lives every year, but like any treatment, they can also carry risks. In recent years, health experts and regulatory agencies have continued to study certain medications that may increase the likelihood of blood clots, heart attacks, or strokes in some individuals. While these side effects are uncommon for many people, understanding the risks can help patients make informed decisions alongside their healthcare providers.
The key point is that not all medications carry the same level of risk, and a medicine that is appropriate for one person may not be the best choice for another. Factors such as age, smoking, high blood pressure, diabetes, obesity, family history, and existing heart disease all play a role in determining an individual’s overall risk.
One group of medications that has received significant attention is hormonal birth control containing estrogen. Combined oral contraceptive pills are safe and effective for many users, but studies have shown they can slightly increase the risk of developing blood clots, particularly in women who smoke, are over age 35, or have certain inherited clotting disorders. For most healthy women, however, the overall risk remains low.
Certain hormone replacement therapies (HRT) used to manage menopause symptoms have also been associated with a higher risk of blood clots and, in some cases, stroke. Healthcare providers often consider a person’s medical history before prescribing these treatments and may recommend alternative options when appropriate.
Some anti-inflammatory medications (NSAIDs), especially when used at high doses or for long periods, have also been linked to an increased risk of cardiovascular events in certain individuals. This is one reason doctors recommend using the lowest effective dose for the shortest necessary time unless directed otherwise.
There have also been discussions about specific medications used for chronic inflammatory conditions, cancer treatments, and other specialized therapies. Regulatory agencies continue monitoring these drugs through ongoing safety reviews, updating prescribing information whenever new evidence becomes available.